Matt Carpenter hits standup bunt double

Getty Images
31 Comments

The wave of defensive shifts we’ve seen over the past few years has led to a lot of armchair hitting coaches demanding that players bunt to beat it. This is easier said than done, however.

The shift happens because certain hitters tend to pull the ball. Certain hitters tend to pull the ball because pulling the ball is what happens when one gets a strong, quick swing on a pitch one identifies early and which one endeavors to send as far away from home plate as possible. Which is to say that pulling is a skill that is good to have and which is strongly selected for among hitters.

In light of that, “why not just bunt to beat the shift” takes are kind of lazy. Bunting is hard! And it is not a thing guys who get shifted a lot are good at. Most of the time asking a player to do a thing he is not well-equipped to do is a bad idea. Indeed, a hitter voluntarily going away from his strength is something the defense would much prefer.

Most of the time anyway.

Last night Matt Carpenter made those armchair hitting coaches happy by laying down a bunt to beat the shift. And he laid it down so well that he ended up with a standup double:

One batter later Carpenter scored on a Starlin Castro error.

The shift giveth and the shift taketh away.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
0 Comments

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.